Works matching IS 01422782 AND DT 2016 AND VI 37 AND IP 6

Results: 9

Issue Information - TOC.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 321, doi. 10.1002/bdd.1978
Publication type:
Article
Issue Information - JIP.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 322, doi. 10.1002/bdd.1979
Publication type:
Article
Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 323, doi. 10.1002/bdd.2014
By:
- Suzuki, Toyofumi;
- Aoyama, Takahiko;
- Suzuki, Naoto;
- Kobayashi, Masaru;
- Fukami, Toshiro;
- Matsumoto, Yoshiaki;
- Tomono, Kazuo
Publication type:
Article
The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 336, doi. 10.1002/bdd.2015
By:
- Endres, Christopher J.;
- Moss, Aaron M.;
- Ishida, Kazuya;
- Govindarajan, Rajgopal;
- Unadkat, Jashvant D.
Publication type:
Article
The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 345, doi. 10.1002/bdd.2016
By:
- Jardan, Yousef A. Bin;
- Brocks, Dion R.
Publication type:
Article
Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 352, doi. 10.1002/bdd.2017
By:
- Kwon, Mi Hye;
- Yoon, Ji Na;
- Baek, Yu Jin;
- Kim, Yu Chul;
- Cho, Yong Yeon;
- Kang, Hee Eun
Publication type:
Article
Simultaneous evaluation of substrate-dependent CYP3A inhibition using a CYP3A probe substrates cocktail.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 366, doi. 10.1002/bdd.2019
By:
- Lee, Eunyoung;
- Shon, Jong Cheol;
- Liu, Kwang‐Hyeon
Publication type:
Article
In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 373, doi. 10.1002/bdd.2020
By:
- Watanabe, Ayahisa;
- Mayumi, Kei;
- Nishimura, Kyohei;
- Osaki, Hiromi
Publication type:
Article
In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9.
Published in:
Biopharmaceutics & Drug Disposition, 2016, v. 37, n. 6, p. 379, doi. 10.1002/bdd.2021
By:
- Iwasaki, Kazuhide;
- Kitsugi, Yusuke;
- Ikeda, Kanami;
- Yoshikawa, Takahiro;
- Hosaka, Shinya;
- Uehara, Shotaro;
- Uno, Yasuhiro;
- Utoh, Masahiro;
- Yamazaki, Hiroshi
Publication type:
Article